PorTal Access, Inc. is committed to designing solutions that aim to reduce complications currently associated with chemo port placement while offering a safe and minimally invasive option for bedside or in an outpatient setting. Flexi-Port™ SLF-TANL™ is currently not available for sale.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/28/25 | $7,000,000 | Series A |
BlakeBrooke Ventures | undisclosed |
